Cited by 152Dementia and Cognitive Impairment ResearchNeurological Disease Mechanisms and TreatmentsAlzheimer's disease research and treatments

The DOI matches its Crossref record; 76 of the 77 references it cites were found in a registry or an index.

Mixed dementia: A review of the evidence

Open access
Custodio, Nilton, Montesinos, Rosa, Lira, David, Herrera-Pérez, Eder, Bardales, Yadira, Valeriano-Lorenzo, Lucía·2017·Dementia & Neuropsychologia

Abstract

ABSTRACT. Mixed dementia is the coexistence of Alzheimer's disease and cerebrovascular disease (CVD) in the same demented patient. Currently, its diagnosis and treatment remains a challenge for practitioners. To provide an overview of the epidemiology, pathogenesis, natural history, diagnosis, and therapy of Mixed Vascular-Alzheimer Dementia (MVAD). The literature was reviewed for articles published between 1990-2016 by using the keywords linked to MVAD. Neuropathological studies indicate that MVAD is a very common pathological finding in the elderly with a prevalence about of 22%. The distinction between Alzheimer's dementia and vascular dementia (VD) is complex because their clinical presentation can overlap. There are international criteria for the MVAD diagnosis. The pharmacologic therapy shows modest clinical benefits that are similar among all drugs used in patients with Alzheimer's dementia and VD. The non-pharmacologic therapy includes the rigorous management of cardiovascular risk factors (especially hypertension) and the promotion of a healthy diet. The diagnosis and treatment of MVAD cannot be improved without further studies. Currently available medications provide only modest clinical benefits once a patient has developed MVAD. In subjects at risk, the antihypertensive therapy and healthy diet should be recommend for preventing or slowing the progression of MVAD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1590/1980-57642016dn11-040005

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Research works printed but not linked: 3

  1. Snowdon DA, 1997, Brain infarction and the clinical expression of Alzheimer disease The Nun Study, JAMA, 277, 813, 10.1001/jama.1997.03540340047031 · DOI · Paper page
  2. Jack CR, 2013, Update on hypothetical model of Alzheimer’s disease biomarkers, Lancet Neurol, 12, 207, 10.1016/S1474-4422(12)70291-0 · DOI · Paper page
  3. Snowdon DA, 1997, Brain infarction and the clinical expression of Alzheimer disease The Nun Study, JAMA, 277, 813, 10.1001/jama.1997.03540340047031 · DOI · Paper page

Cited by

Sorted by citations

See all 152

Metadata

Authors
Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., & Valeriano-Lorenzo, L.
Affiliations
  • Instituto Peruano de Neurociencias (PE)
  • Instituto Peruano de Neurociencias, Perú; Instituto Nacional de Salud del Niño, Perú; GESID, Peru
Corresponding author
Custodio, Nilton
Venue
Dementia & Neuropsychologia
Published
2017-12
Volume
11
Issue
4
Pages
364-370
ISSN
1980-5764 (ISSN-L)
OpenAlex
W2784098514
Cited by
148
References
77
Citations by year
2026: 16 · 2025: 26 · 2024: 15 · 2023: 27 · 2022: 17 · 2021: 14 · 2020: 13 · 2019: 13 · 2018: 7
FWCI
7.42
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Dementia & Neuropsychologia (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
  • Americanae (AECID Library) (submittedVersion, cc-by-nc)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Redalyc (Universidad Autónoma del Estado de México) (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords
Alzheimer's disease, cerebrovascular disease, vascular dementia, dementia diagnosis, dementia pathogenesis, dementia epidemiology, natural history of dementia, pharmacotherapy, non-pharmacological treatment, cardiovascular risk factors, hypertension, healthy eating, dementia prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review